A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. [PDF]
Yu S +13 more
europepmc +1 more source
Сравнительный анализ производительности СУБД с использованием OLAP и OLTP запросов [PDF]
Левин Максим Юрьевич. Сравнительный анализ производительности СУБД с использованием OLAP и OLTP запросов. Научный руководитель: доктор физико-математических наук, профессор Новиков Борис Асенович.
Levin Maksim +1 more
core
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine. [PDF]
Sakai F +8 more
europepmc +1 more source
Este projeto propõe a utilização de sistemas OLTP (Processamento Transacional On-Line 2 no gerenciamento do fluxo de informações entre os segmentos de um ambiente de manufatura integrada voltado à produção discreta. Para tanto, são analisados os aspectos
Brigante, Wellington Jose
core
Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia.
Rosenson RS +9 more
europepmc +1 more source
HyPer: HYbrid OLTP&OLAP High PERformance Database System
The two areas of online transaction processing (OLTP) and online analytical processing (OLAP) present different challenges for database architectures. Currently, customers with high rates of mission-critical transactions have split their data into two ...
Alfons Kemper;Thomas Neumann
core
Effectiveness of surgical treatments on healing of cartilage and function level in patients with osteochondral lesions of the tibial plafond: A systematic review. [PDF]
Jagtenberg EM +5 more
europepmc +1 more source
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension. [PDF]
Lipton RB +10 more
europepmc +1 more source
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial. [PDF]
Ashina M +9 more
europepmc +1 more source
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials. [PDF]
Tepper SJ +11 more
europepmc +1 more source

